Brief: Guangzhou Innogen Pharmaceutical & Unit Subscribes For Structured Deposit Product
03/11/2025 13:22
Nov 3 (Reuters) - Guangzhou Innogen Pharmaceutical Group Co Ltd 2591.HK: CO & UNIT SUBSCRIBED FOR STRUCTURED DEPOSIT PRODUCT FROM THE BANK OF NINGBO FOR RMB105 MILLION IN AGGREGATE Further company coverage: 2591.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Guangzhou Innogen Pharmaceutical
See all newsBrief: Guangzhou Innogen Pharmaceutical Appoints Jin Bai As Vice President
Brief: Guangzhou Innogen Pharmaceutical Says Xu Wenjie Resigns As Executive Director
Brief: Guangzhou Innogen Pharmaceutical Group Co's Founder, Senior Management Undertakes Six-Month Lock-Up
Brief: Guangzhou Innogen Pharmaceutical Announces Intention To Conduct On-Market H Share Repurchase
Brief: GUANGZHOU INNOGEN PHARMACEUTICAL Posts HY LOSS Of RMB115.5 MLN